Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical firms, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to do so may possibly be grounds for compensation. Our lawyers are functioning challenging to obtain these hurt by the drug the compensation they're entitled to.













image class="left" url="https://images56.fotki.com/v1298/photos/2/3651632/13703394/LOGO-vi.jpg"Whilst bleeding is a frequent complication associated with anticoagulants, it has been alleged that Xarelto is far more dangerous than standard blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, within the event of an emergency, patients could be at danger for irreversible bleeding difficulties, reference such as life-threatening internal and gastrointestinal hemorrhaging.













In the event you or perhaps a loved one particular suffered a severe bleeding event soon after taking Xarelto, you might have legal recourse. For far more information, make contact with us these days to have your case reviewed, cost-free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in instances of death, funeral expenses. Additionally, they may be seeking punitive damages, that are usually awarded to punish the defendant and deter other organizations from acting similarly.






Why Are Lawsuits Becoming Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a protected anticoagulant option.






Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.













Visit this page for a lot more data on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













image class="left" url="http://media1.picsearch.com/is?k5M3IZSRVeQ15XclLeOXcRpVMvjCYXJq5SGnpFjutEs&height=231"The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki